Physician profile
Benjamin Bauer
NPI 1417392481
$6,969.51
in general payments reported to CMS, 2019-2025
26 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,313 · 2020: $3,488 · 2021: $1,385 · 2022: $312 · 2023: $225 · 2024: $96.18 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $4,880.01 | 2019-2021 | |
| Arthrex, INC. | $567.24 | 2020 | |
| Smith+Nephew, INC. | $211.51 | 2019-2023 | Regranex, Collagenase Santyl |
| Zimmer Biomet Holdings, INC. | $183.18 | 2019-2020 | |
| Trimed, INC. | $147.70 | 2022 | |
| Stryker Corporation | $132.25 | 2020-2024 | Prostep Mica |
| Treace Medical Concepts, INC. | $124.59 | 2023-2025 | |
| Organogenesis INC. | $122.53 | 2021-2023 | Puraply |
| Abbvie INC. | $76.61 | 2021-2022 | |
| Horizon Therapeutics Plc | $68.38 | 2019-2023 | Krystexxa |
| Abbott Laboratories | $65.17 | 2023-2024 | Proclaim |
| Bioventus LLC | $63.17 | 2019-2023 | |
| Orthofix Medical, INC. | $52.33 | 2019-2025 | Physio-Stim |
| Kowa Pharmaceuticals America, INC. | $43.83 | 2022-2023 | Seglentis |
| Merck Sharp & Dohme LLC | $33.47 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $30.84 | 2022 | |
| Integra Lifesciences Corporation | $24.28 | 2023 | Tenoglide |
| Cardiovascular Systems INC. | $21.15 | 2020 | |
| Solventum Corporation | $20.32 | 2024 | Prevena, V.A.C. Veraflo |
| Ani Pharmaceuticals, INC. | $18.73 | 2025 | Purified Cortrophin Gel |
| Amgen INC. | $17.46 | 2025 | Krystexxa |
| Melinta Therapeutics, LLC | $14.24 | 2019 | |
| Medtronic, INC. | $13.55 | 2025 | Inceptiv |
| Wright Medical Technology, INC. | $13.16 | 2019 | |
| Tactile Systems Technology INC | $12.35 | 2020 | |
| Zyla Life Sciences, INC. | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.